Patient Guide: Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 14 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05984199
Status: TERMINATED
Condition: Leukemia, Myeloid, Acute
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 14 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • La Jolla, California
  • Stanford, California
  • Miami, Florida
  • • And 11 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily